Heil J - Search Results

1

Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.

Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Degenhardt T, Rom J, Rody A, van Mackelenbergh M, Banys-Paluchowski M, Große R, Reinisch M, Karsten M, Golatta M, Heil J. Pfob A, et al. Among authors: heil j. J Clin Oncol. 2022 Jun 10;40(17):1903-1915. doi: 10.1200/JCO.21.02439. Epub 2022 Feb 2. J Clin Oncol. 2022. PMID: 35108029 Clinical Trial.

2

Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).

Heil J, Holl S, Golatta M, Rauch G, Rom J, Marmé F, Gebauer G, Sohn C. Heil J, et al. Breast. 2010 Dec;19(6):470-4. doi: 10.1016/j.breast.2010.05.004. Epub 2010 Jun 3. Breast. 2010. PMID: 20627726 Free article.

3

Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations?

Heil J, Dahlkamp J, Golatta M, Rom J, Domschke C, Rauch G, Cardoso MJ, Sohn C. Heil J, et al. Ann Surg Oncol. 2011 Jan;18(1):134-8. doi: 10.1245/s10434-010-1252-4. Epub 2010 Aug 10. Ann Surg Oncol. 2011. PMID: 20697820 Clinical Trial.

4

Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.

Domschke C, Schuetz F, Ge Y, Rom J, Zorn M, Sinn HP, Marmé F, Schott S, Heil J, Scharf A, Sohn C, Schneeweiss A, Beckhove P. Domschke C, et al. Among authors: heil j. Cancer Immunol Immunother. 2011 Mar;60(3):401-11. doi: 10.1007/s00262-010-0956-4. Epub 2010 Dec 14. Cancer Immunol Immunother. 2011. PMID: 21161218 Free PMC article.

5

Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions?

Heil J, Bühler A, Golatta M, Rom J, Harcos A, Schipp A, Rauch G, Junkermann H, Sohn C. Heil J, et al. Ann Surg Oncol. 2011 Aug;18(8):2143-9. doi: 10.1245/s10434-011-1565-y. Epub 2011 Feb 3. Ann Surg Oncol. 2011. PMID: 21290193 Clinical Trial.

6

Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study.

Heil J, Breitkreuz K, Golatta M, Czink E, Dahlkamp J, Rom J, Schuetz F, Blumenstein M, Rauch G, Sohn C. Heil J, et al. Ann Surg Oncol. 2012 Feb;19(2):541-7. doi: 10.1245/s10434-011-1947-1. Epub 2011 Jul 15. Ann Surg Oncol. 2012. PMID: 21761099 Clinical Trial.

7

Objective assessment of aesthetic outcome after breast conserving therapy: subjective third party panel rating and objective BCCT.core software evaluation.

Heil J, Carolus A, Dahlkamp J, Golatta M, Domschke C, Schuetz F, Blumenstein M, Rauch G, Sohn C. Heil J, et al. Breast. 2012 Feb;21(1):61-5. doi: 10.1016/j.breast.2011.07.013. Epub 2011 Aug 17. Breast. 2012. PMID: 21852135 Free article.

8

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.

Ge Y, Domschke C, Stoiber N, Schott S, Heil J, Rom J, Blumenstein M, Thum J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F. Ge Y, et al. Among authors: heil j. Cancer Immunol Immunother. 2012 Mar;61(3):353-62. doi: 10.1007/s00262-011-1106-3. Epub 2011 Sep 14. Cancer Immunol Immunother. 2012. PMID: 21915801 Free PMC article. Clinical Trial.

9

Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.

Garcia-Etienne CA, Tomatis M, Heil J, Friedrichs K, Kreienberg R, Denk A, Kiechle M, Lorenz-Salehi F, Kimmig R, Emons G, Danaei M, Heyl V, Heindrichs U, Rageth CJ, Janni W, Marotti L, del Turco MR, Ponti A; eusomaDB Working Group. Garcia-Etienne CA, et al. Among authors: heil j. Eur J Cancer. 2012 Sep;48(13):1947-56. doi: 10.1016/j.ejca.2012.03.008. Epub 2012 Apr 4. Eur J Cancer. 2012. PMID: 22483323

10

Predictors of resectability in breast-conserving therapy.

Rath MG, Heil J, Domschke C, Topic Z, Schneider S, Sinn HP, Marme F, Scharf A, Schneeweiss A, Sohn C, Rom J. Rath MG, et al. Among authors: heil j. Arch Gynecol Obstet. 2012 Oct;286(4):1023-31. doi: 10.1007/s00404-012-2401-8. Epub 2012 Jun 17. Arch Gynecol Obstet. 2012. PMID: 22707290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

420 results

Search Page